UCLA Health Jonsson Comprehensive Cancer Center scientists identify germline signature that predicts side effects from anti-PD1/PDL1 checkpoint therapy

Findings represent an important step toward personalizing checkpoint therapy
DNA strand and immune cells
Adobe Stock image by Vladimircaribb